HMGCR and female reproductive organ cancer: Interestingly, previous studies did show that lipophilic statins seem to confer more remarkable anticancer efficacy than hydrophilic statins in some cancers, such as in gynecological cancers expressing high levels of HMG-CoA reductase [32].